Related Experiment Video

Updated: Jun 10, 2026

Comparative Lesions Analysis Through a Targeted Sequencing Approach
08:16

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

Novel CDKN2A mutation detected in Spanish melanoma pedigree

Carlos de Torre, Jorge Martínez-Escribano

    Experimental Dermatology
    |July 27, 2010
    PubMed

    Insights

    Genetic analysis of melanoma-predisposing genes CDKN2A and CDK4 in Spanish families revealed four CDKN2A alterations. A novel deletion, p.M54del, was identified, impacting p16INK4A interaction with cdk6.

    Area of Science:

    • Genetics
    • Oncology
    • Molecular Biology

    Background:

    • Investigated alterations in cyclin-dependent kinase inhibitor 2A (CDKN2A) and cyclin-dependent kinase 4 (CDK4) genes.
    • Focused on a Spanish population with a high prevalence of melanoma, including 61 patients from 45 families.

    Discussion:

    • Identified four distinct CDKN2A alterations in seven melanoma kindreds.
    • Three previously described mutations (p.G101W, p.V59G, c.358delG) were found in the Mediterranean population.
    • Discovered a novel deletion (p.M54del) in a melanoma kindred, affecting a critical residue for p16INK4A-cdk6 interaction.

    Key Insights:

    • The novel p.M54del deletion in CDKN2A is a significant finding, previously unreported in melanoma or other cancers.
    • This deletion impacts the interaction between p16INK4A and cdk6, potentially disrupting cell cycle regulation.
    • Highlights the genetic heterogeneity of melanoma predisposition within the Spanish population.

    Outlook:

    • Further investigation into the functional consequences of the p.M54del mutation is warranted.
    • Broader screening for CDKN2A alterations in diverse populations may reveal additional novel mutations.
    • Understanding these genetic variations can improve melanoma risk assessment and personalized treatment strategies.

    More Related Videos

    A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia05:51

    A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia

    Published on: June 15, 2011

    Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors11:15

    Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

    Published on: September 20, 2016

    Related Concept Videos

    Cancers Originate from Somatic Mutations in a Single Cell02:21

    Cancers Originate from Somatic Mutations in a Single Cell

    Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
    Cancers Originate from Somatic Mutations in a Single Cell02:21

    Cancers Originate from Somatic Mutations in a Single Cell

    Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
    Cancer-Critical Genes II: Tumor Suppressor Genes01:05

    Cancer-Critical Genes II: Tumor Suppressor Genes

    Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
    When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
    Such genes that act...
    Cancer-Critical Genes II: Tumor Suppressor Genes01:05

    Cancer-Critical Genes II: Tumor Suppressor Genes

    Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
    When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
    Such genes that act...
    M-Cdk Drives Transition Into Mitosis02:15

    M-Cdk Drives Transition Into Mitosis

    Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
    Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
    M cyclin...
    Inhibition of Cdk Activity02:34

    Inhibition of Cdk Activity

    The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...